The state of the art in core-shell-type lipid-polymer hybrid nanocarriers and beyond

被引:6
作者
Sengel-Turk, Ceyda Tuba [1 ]
Paksoy, Ahmet Oguzhan [2 ]
Alpturk, Onur [2 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkiye
[2] Istanbul Tech Univ, Dept Chem, Maslak, Istanbul, Turkiye
关键词
Core-shell structure; Lipid-polymer hybrid nanocarriers; Drug delivery; Biomedical applications; Cancer; Theranostics; COATED PLGA NANOPARTICLES; DRUG-DELIVERY; IN-VITRO; TARGETED DELIVERY; PLATFORM; DESIGN; OPTIMIZATION; DOXORUBICIN; RELEASE; ORGANIZATION;
D O I
10.1007/s00289-023-04951-x
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
The emergence of drug delivery systems stems from the need to enhance the therapeutic effectiveness of drugs while minimizing their side effects. With the advent of nanotechnology, a wide range of molecular structures, including carbon nanotubes and polymeric materials, have been developed, leading to significant advancements in the field. However, despite these promising outcomes, it is imperative to note that drug delivery systems do not provide a universal solution to all challenges in pharmaceutical technology; as each system possesses certain advantages and limitations. As a result, researchers turned their attention to the creation of new hybrid structures by combining different materials. Among these, lipid-polymer hybrid particles gained considerable attention in the academic community; these particles exhibit a core-shell structure, wherein a polymer core is enveloped by a layer of phospholipids. This manuscript serves as an overview of the fundamental aspects of these molecular architectures, starting with a comprehensive description of lipid-polymer hybrid particles. Subsequently, both conventional and unconventional production methods for fabricating these structures are discussed. The characterization of the physical properties of these particles and their influence on pharmaceutical activity are explored in a subsequent section. Finally, notable examples from the literature are presented.
引用
收藏
页码:4771 / 4800
页数:30
相关论文
共 88 条
[51]   The Advances and Challenges of Liposome-Assisted Drug Release in the Presence of Serum Albumin Molecules: The Influence of Surrounding pH [J].
Pentak, Danuta ;
Ploch-Jankowska, Anna ;
Zieba, Andrzej ;
Kozik, Violetta .
MATERIALS, 2022, 15 (04)
[52]   Mediating Tumor Targeting Efficiency of Nanoparticles Through Design [J].
Perrault, Steven D. ;
Walkey, Carl ;
Jennings, Travis ;
Fischer, Hans C. ;
Chan, Warren C. W. .
NANO LETTERS, 2009, 9 (05) :1909-1915
[53]   Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach [J].
Rose, Fabrice ;
Wern, Jeanette Erbo ;
Ingvarsson, Pall Thor ;
van de weert, Marco ;
Andersen, Peter ;
Follmann, Frank ;
Foged, Camilla .
JOURNAL OF CONTROLLED RELEASE, 2015, 210 :48-57
[54]   Hybrid nanocapsules: Interactions of ABA block copolymers with liposomes [J].
Ruysschaert, T ;
Sonnen, AFP ;
Haefele, T ;
Meier, W ;
Winterhaltert, M ;
Fournier, D .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (17) :6242-6247
[55]   Antibacterial and antitumor activities of 3-amino-phenyl-4(3H)-quinazolinone/polypyrrole chitosan core shell nanoparticles [J].
Salahuddin, Nehal ;
Elbarbary, Ahmed A. ;
Alkabes, Hend A. .
POLYMER BULLETIN, 2017, 74 (05) :1775-1790
[56]   Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups [J].
Salvador-Morales, Carolina ;
Zhang, Liangfang ;
Langer, Robert ;
Farokhzad, Omid C. .
BIOMATERIALS, 2009, 30 (12) :2231-2240
[57]  
Schafer J., 2008, Advances in Science and Technology, V57, P148, DOI 10.4028/www.scientific.net/AST.57.148
[58]   Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid-polymer hybrid nanoparticles: In vitro and in silico studies [J].
Seedat, Nasreen ;
Kalhapure, Rahul S. ;
Mocktar, Chunderika ;
Vepuri, Suresh ;
Jadhav, Mahantesh ;
Soliman, Mahmoud ;
Govender, Thirumala .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2016, 61 :616-630
[59]   Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part I. Formulation optimization using a design of experiment approach [J].
Sengel-Turk, C. Tuba ;
Hascicek, Canan .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 39 :16-27
[60]   Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells [J].
Sengel-Turk, C. Tuba ;
Hascicek, Canan ;
Dogan, A. Lale ;
Esendagli, Gunes ;
Guc, Dicle ;
Gonul, Nursin .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (09) :1107-1116